Immunome, Inc. (NASDAQ:IMNM) shares fell sharply by 9.6% following the announcement of the pricing of its upsized public offering of common stock. The biotechnology company, known for its work on ...
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
Robinhood CEO Vlad Tenev’s proposal for tokenized equity sales offers a sensible third way between exempt securities and public offerings, deepening the capital available to businesses of all sizes, ...
The lawyer behind a series of high-profile legal challenges to DEI practices is suing Bally’s and the city of Chicago over a $250 million IPO the suit says is unlawfully open only to people of color ...